TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
XGN

Exagen Inc

Healthcare · Diagnostics & Research

8.60$ -2.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XGN
Line item 2012 2013 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +46.0% +4.2% -14.7% +39.4% +41.7% +205.7% -11.3% +57.5% -30.2% -34.0% -21.5% +29.8%
– +124.8% -36.7% -23.9% +243.0% +60.7% +281.2% -13.2% +59.9% -35.6% -34.1% -23.8% +34.1%
– +182.1% -40.5% -45.5% +348.0% +17.1% +447.6% -20.3% +73.1% -37.3% -41.5% -39.6% +46.2%
– +182.1% -40.5% -45.5% +348.0% +17.1% +447.6% -20.3% +73.1% -37.3% -41.5% -39.6% +46.2%
– – – – – +885.4% -4.0% +55.9% +8.4% -37.1% +7.8% +19.6% +38.5%
– – – – – +87.9% +39.6% -15.7% -9.3% +64.5% +59.9% – –
– – +25.2% +3.6% -15.7% +16.6% -11.9% +52.3% +127.0% +174.1% – – –
– +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% -100.0% – – –
– -17.3% -21.5% -36.1% -72.6% -100.0% – +0.0% +0.0% – – – –
– +148.3% +95.0% +18.0% -32.0% +42.3% -8.3% +11.9% +5.4% +13.6% -21.7% +2.6% +15.4%
– +342.3% +148.2% +33.0% -85.7% +79.4% -34.1% +48.8% +6.2% +3.3% +23.7% +13.5% +4.8%
– +630.7% +107.7% +39.9% -99.9% +200.0% +193.8% +29.4% +90.6% +228.8% -35.8% +38.7% +74.7%
– +28.9% +316.1% +18.7% -18.8% -27.8% +15.4% +104.2% -17.3% +22.2% +2.8% +32.1% +0.4%
– – – – – +30.9% +5.0% +3.1% +3.1% +4.7% -33.2% +3.1% +12.3%
– -90.6% -3,216.6% – – – – -24.8% +103.0% -50.0% -46.6% -58.0% +82.9%
– – – – – – – – – – – – –
– +51.6% +5.0% +11.4% +0.3% +0.0% +19,836.5% +0.7% +26.2% +7.0% +3.5% +3.0% +18.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?